Report Detail

Food & Beverages Global and China Neuropeptide Y Receptor Market Insights, Forecast to 2026

  • RnM4200529
  • |
  • 11 September, 2020
  • |
  • Global
  • |
  • 127 Pages
  • |
  • QYResearch
  • |
  • Food & Beverages

1 Study Coverage

  • 1.1 Neuropeptide Y Receptor Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Neuropeptide Y Receptor Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Type
    • 1.4.2 Food Grade
    • 1.4.3 Pharmaceutical Grade
  • 1.5 Market by Application
    • 1.5.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Application
    • 1.5.2 Medicine
    • 1.5.3 Food Additives
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Neuropeptide Y Receptor Market Size, Estimates and Forecasts
    • 2.1.1 Global Neuropeptide Y Receptor Revenue 2015-2026
    • 2.1.2 Global Neuropeptide Y Receptor Sales 2015-2026
  • 2.2 Global Neuropeptide Y Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Neuropeptide Y Receptor Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Neuropeptide Y Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Neuropeptide Y Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Neuropeptide Y Receptor Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Neuropeptide Y Receptor Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Neuropeptide Y Receptor Revenue Forecast by Region (2021-2026)

3 Global Neuropeptide Y Receptor Competitor Landscape by Players

  • 3.1 Global Top Neuropeptide Y Receptor Sales by Manufacturers
    • 3.1.1 Global Neuropeptide Y Receptor Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Neuropeptide Y Receptor Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Neuropeptide Y Receptor Manufacturers by Revenue
    • 3.2.1 Global Neuropeptide Y Receptor Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Neuropeptide Y Receptor Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Neuropeptide Y Receptor Revenue in 2019
    • 3.2.5 Global Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Neuropeptide Y Receptor Price by Manufacturers
  • 3.4 Global Neuropeptide Y Receptor Manufacturing Base Distribution, Product Types
    • 3.4.1 Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Neuropeptide Y Receptor Product Type
    • 3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Neuropeptide Y Receptor Market Size by Type (2015-2020)
    • 4.1.1 Global Neuropeptide Y Receptor Sales by Type (2015-2020)
    • 4.1.2 Global Neuropeptide Y Receptor Revenue by Type (2015-2020)
    • 4.1.3 Neuropeptide Y Receptor Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Neuropeptide Y Receptor Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Neuropeptide Y Receptor Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Type (2021-2026)
    • 4.2.3 Neuropeptide Y Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Neuropeptide Y Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Neuropeptide Y Receptor Market Size by Application (2015-2020)
    • 5.1.1 Global Neuropeptide Y Receptor Sales by Application (2015-2020)
    • 5.1.2 Global Neuropeptide Y Receptor Revenue by Application (2015-2020)
    • 5.1.3 Neuropeptide Y Receptor Price by Application (2015-2020)
  • 5.2 Neuropeptide Y Receptor Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Neuropeptide Y Receptor Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Neuropeptide Y Receptor Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

  • 6.1 China Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
    • 6.1.1 China Neuropeptide Y Receptor Sales YoY Growth 2015-2026
    • 6.1.2 China Neuropeptide Y Receptor Revenue YoY Growth 2015-2026
    • 6.1.3 China Neuropeptide Y Receptor Market Share in Global Market 2015-2026
  • 6.2 China Neuropeptide Y Receptor Market Size by Players (International and Local Players)
    • 6.2.1 China Top Neuropeptide Y Receptor Players by Sales (2015-2020)
    • 6.2.2 China Top Neuropeptide Y Receptor Players by Revenue (2015-2020)
  • 6.3 China Neuropeptide Y Receptor Historic Market Review by Type (2015-2020)
    • 6.3.1 China Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
    • 6.3.2 China Neuropeptide Y Receptor Revenue Market Share by Type (2015-2020)
    • 6.3.3 China Neuropeptide Y Receptor Price by Type (2015-2020)
  • 6.4 China Neuropeptide Y Receptor Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 China Neuropeptide Y Receptor Sales Forecast by Type (2021-2026)
    • 6.4.2 China Neuropeptide Y Receptor Revenue Forecast by Type (2021-2026)
    • 6.4.3 China Neuropeptide Y Receptor Price Forecast by Type (2021-2026)
  • 6.5 China Neuropeptide Y Receptor Historic Market Review by Application (2015-2020)
    • 6.5.1 China Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
    • 6.5.2 China Neuropeptide Y Receptor Revenue Market Share by Application (2015-2020)
    • 6.5.3 China Neuropeptide Y Receptor Price by Application (2015-2020)
  • 6.6 China Neuropeptide Y Receptor Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 China Neuropeptide Y Receptor Sales Forecast by Application (2021-2026)
    • 6.6.2 China Neuropeptide Y Receptor Revenue Forecast by Application (2021-2026)
    • 6.6.3 China Neuropeptide Y Receptor Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
  • 7.2 North America Neuropeptide Y Receptor Market Facts & Figures by Country
    • 7.2.1 North America Neuropeptide Y Receptor Sales by Country (2015-2020)
    • 7.2.2 North America Neuropeptide Y Receptor Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
  • 8.2 Europe Neuropeptide Y Receptor Market Facts & Figures by Country
    • 8.2.1 Europe Neuropeptide Y Receptor Sales by Country
    • 8.2.2 Europe Neuropeptide Y Receptor Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Neuropeptide Y Receptor Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Neuropeptide Y Receptor Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Neuropeptide Y Receptor Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
  • 10.2 Latin America Neuropeptide Y Receptor Market Facts & Figures by Country
    • 10.2.1 Latin America Neuropeptide Y Receptor Sales by Country
    • 10.2.2 Latin America Neuropeptide Y Receptor Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Neuropeptide Y Receptor Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Neuropeptide Y Receptor Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Neuropeptide Y Receptor Sales by Country
    • 11.2.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 UAE

12 Company Profiles

  • 12.1 Gila Therapeutics
    • 12.1.1 Gila Therapeutics Corporation Information
    • 12.1.2 Gila Therapeutics Description and Business Overview
    • 12.1.3 Gila Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
    • 12.1.5 Gila Therapeutics Recent Development
  • 12.2 Novo Nordisk
    • 12.2.1 Novo Nordisk Corporation Information
    • 12.2.2 Novo Nordisk Description and Business Overview
    • 12.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novo Nordisk Neuropeptide Y Receptor Products Offered
    • 12.2.5 Novo Nordisk Recent Development
  • 12.3 XL-protein
    • 12.3.1 XL-protein Corporation Information
    • 12.3.2 XL-protein Description and Business Overview
    • 12.3.3 XL-protein Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 XL-protein Neuropeptide Y Receptor Products Offered
    • 12.3.5 XL-protein Recent Development
  • 12.4 Lilly Eli
    • 12.4.1 Lilly Eli Corporation Information
    • 12.4.2 Lilly Eli Description and Business Overview
    • 12.4.3 Lilly Eli Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Lilly Eli Neuropeptide Y Receptor Products Offered
    • 12.4.5 Lilly Eli Recent Development
  • 12.5 Novartis
    • 12.5.1 Novartis Corporation Information
    • 12.5.2 Novartis Description and Business Overview
    • 12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Novartis Neuropeptide Y Receptor Products Offered
    • 12.5.5 Novartis Recent Development
  • 12.6 Pfizer
    • 12.6.1 Pfizer Corporation Information
    • 12.6.2 Pfizer Description and Business Overview
    • 12.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Pfizer Neuropeptide Y Receptor Products Offered
    • 12.6.5 Pfizer Recent Development
  • 12.7 Merck & Co
    • 12.7.1 Merck & Co Corporation Information
    • 12.7.2 Merck & Co Description and Business Overview
    • 12.7.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Merck & Co Neuropeptide Y Receptor Products Offered
    • 12.7.5 Merck & Co Recent Development
  • 12.8 Mannkind
    • 12.8.1 Mannkind Corporation Information
    • 12.8.2 Mannkind Description and Business Overview
    • 12.8.3 Mannkind Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Mannkind Neuropeptide Y Receptor Products Offered
    • 12.8.5 Mannkind Recent Development
  • 12.9 Gilead Sciences
    • 12.9.1 Gilead Sciences Corporation Information
    • 12.9.2 Gilead Sciences Description and Business Overview
    • 12.9.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Gilead Sciences Neuropeptide Y Receptor Products Offered
    • 12.9.5 Gilead Sciences Recent Development
  • 12.10 Genentech
    • 12.10.1 Genentech Corporation Information
    • 12.10.2 Genentech Description and Business Overview
    • 12.10.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 Genentech Neuropeptide Y Receptor Products Offered
    • 12.10.5 Genentech Recent Development
  • 12.11 Gila Therapeutics
    • 12.11.1 Gila Therapeutics Corporation Information
    • 12.11.2 Gila Therapeutics Description and Business Overview
    • 12.11.3 Gila Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
    • 12.11.5 Gila Therapeutics Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Neuropeptide Y Receptor Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Neuropeptide Y Receptor Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Neuropeptide Y Receptor market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Neuropeptide Y Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Neuropeptide Y Receptor market is segmented into
    Food Grade
    Pharmaceutical Grade

    Segment by Application, the Neuropeptide Y Receptor market is segmented into
    Medicine
    Food Additives
    Others

    Regional and Country-level Analysis
    The Neuropeptide Y Receptor market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Neuropeptide Y Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Neuropeptide Y Receptor Market Share Analysis
    Neuropeptide Y Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuropeptide Y Receptor business, the date to enter into the Neuropeptide Y Receptor market, Neuropeptide Y Receptor product introduction, recent developments, etc.
    The major vendors covered:
    Gila Therapeutics
    Novo Nordisk
    XL-protein
    Lilly Eli
    Novartis
    Pfizer
    Merck & Co
    Mannkind
    Gilead Sciences
    Genentech


    Summary:
    Get latest Market Research Reports on Neuropeptide Y Receptor. Industry analysis & Market Report on Neuropeptide Y Receptor is a syndicated market report, published as Global and China Neuropeptide Y Receptor Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of Neuropeptide Y Receptor market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,010.72
    4,516.08
    6,021.44
    3,293.05
    4,939.58
    6,586.11
    407,511.00
    611,266.50
    815,022.00
    286,696.02
    430,044.03
    573,392.04
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report